Intergroup Trial of Adjuvant Chemotherapy in Adenocarcinoma of the Stomach
Status:
Completed
Trial end date:
2013-01-01
Target enrollment:
Participant gender:
Summary
Open label, randomised, multicenter, superiority study for efficacy. Patients with
histologically proven adenocarcinoma of the stomach or gastroesophageal junction without
gross or microscopic evidence of residual disease after surgery with curative intent and
fulfilling all the inclusion/exclusion criteria are eligible for this study.
Phase:
Phase 3
Details
Lead Sponsor:
Mario Negri Institute for Pharmacological Research
Collaborators:
Aventis Pharmaceuticals Gruppo Italiano per lo studio dei Carcinomi dell'Apparato Digerente Gruppo Oncologico del Nord-Ovest Gruppo Oncologico Italiano di Ricerca Clinica Istituto Scientifico Romagnolo per lo Studio e la cura dei Tumori Italian Trial in Medical Oncology Oncotech Southern Italy Cooperative Oncology Group